.svg){kind=small}
Orforglipron: The First Oral GLP-1
Can a Pill Compete with Surgery?
Blog
SLU-PP-332: The Next-Generation Mitochondrial Booster for Fat Loss and Longevity
SLU-PP-332 is an experimental small molecule developed at Saint Louis University that targets Estrogen-Related Receptor Alpha (ERRα), a key nuclear...
Retatrutide: The Triple-Action Weight Loss Drug That Could Outperform Bariatric Surgery
Scientists have unveiled what may be the most powerful weight loss medication ever developed. Retatrutide, a first-of-its-kind triple-hormone drug,...
Do Weight Loss Clinics Work? An In-Depth Look at Effectiveness and Success Rates
With more than 40% of adults in the U.S. affected by obesity—and nearly 10% facing severe obesity—finding effective weight loss solutions has never...